Search research articles
Contact Us
Filters
Showing results (41-50 of 121) with videos related to
Page
of 13
Sort By:
Cancer Biology & Therapy
|
November 15, 2018
Vemurafenib-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemia cutis
Nina Anika Richarz, Luis Puig, Noelia Pérez, et al.
The American Journal of Dermatopathology
|
June 8, 2010
Grover disease: a reappraisal of histopathological diagnostic criteria in 120 cases
María-Teresa Fernández-Figueras, Luis Puig, Pablo Cannata, et al.
The Journal of Clinical and Aesthetic Dermatology
|
February 15, 2021
Early Treatment Targets for Predicting Long-term Dermatology Life Quality Index Response in Patients with Moderate-to-Severe Plaque Psoriasis: A <i>Post-hoc</i> Analysis from a Long-term Clinical Study
Luis Puig, Baojin Zhu, Russel Burge, et al.
Dermatology and Therapy
|
October 22, 2022
A Response to: Letter to the Editor Regarding Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
April W Armstrong, Ahmed M Soliman, Keith A Betts, et al.
Dermatology and Therapy
|
March 31, 2021
Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
April W Armstrong, Ahmed M Soliman, Keith A Betts, et al.
Advances in Therapy
|
July 17, 2025
Real-World Evidence for Ixekizumab in the Treatment of Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: Systematic Literature Review 2022-2023
Luis Puig, Philipp Sewerin, Christopher Schuster, et al.
Acta Dermato-Venereologica
|
September 14, 2017
Dystrophic Calcification in a Patient with Primary Localized Cutaneous Nodular Amyloidosis: An Uncommon Ultrasound Finding
Sergi Planas-Ciudad, Esther Roé Crespo, Juan Francisco Mir-Bonafé, et al.
The Journal of Dermatological Treatment
|
October 16, 2019
Consistent response to guselkumab treatment between Hispanic and non-Hispanic patients with psoriasis: an analysis from VOYAGE 1 and VOYAGE 2
Luis Puig, Jashin J Wu, Melinda J Gooderham, et al.
Dermatology and Therapy
|
December 4, 2021
Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis
April W Armstrong, Ahmed M Soliman, Keith A Betts, et al.
Dermatology and Therapy
|
May 10, 2024
Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study
Andreas Pinter, Ahmed M Soliman, Irina Pivneva, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 121) with videos related to
Sort By:
Page
of 13
Cancer Biology & Therapy
|
November 15, 2018
Vemurafenib-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemia cutis
Nina Anika Richarz, Luis Puig, Noelia Pérez, et al.
The American Journal of Dermatopathology
|
June 8, 2010
Grover disease: a reappraisal of histopathological diagnostic criteria in 120 cases
María-Teresa Fernández-Figueras, Luis Puig, Pablo Cannata, et al.
The Journal of Clinical and Aesthetic Dermatology
|
February 15, 2021
Early Treatment Targets for Predicting Long-term Dermatology Life Quality Index Response in Patients with Moderate-to-Severe Plaque Psoriasis: A <i>Post-hoc</i> Analysis from a Long-term Clinical Study
Luis Puig, Baojin Zhu, Russel Burge, et al.
Dermatology and Therapy
|
October 22, 2022
A Response to: Letter to the Editor Regarding Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
April W Armstrong, Ahmed M Soliman, Keith A Betts, et al.
Dermatology and Therapy
|
March 31, 2021
Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
April W Armstrong, Ahmed M Soliman, Keith A Betts, et al.
Advances in Therapy
|
July 17, 2025
Real-World Evidence for Ixekizumab in the Treatment of Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: Systematic Literature Review 2022-2023
Luis Puig, Philipp Sewerin, Christopher Schuster, et al.
Acta Dermato-Venereologica
|
September 14, 2017
Dystrophic Calcification in a Patient with Primary Localized Cutaneous Nodular Amyloidosis: An Uncommon Ultrasound Finding
Sergi Planas-Ciudad, Esther Roé Crespo, Juan Francisco Mir-Bonafé, et al.
The Journal of Dermatological Treatment
|
October 16, 2019
Consistent response to guselkumab treatment between Hispanic and non-Hispanic patients with psoriasis: an analysis from VOYAGE 1 and VOYAGE 2
Luis Puig, Jashin J Wu, Melinda J Gooderham, et al.
Dermatology and Therapy
|
December 4, 2021
Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis
April W Armstrong, Ahmed M Soliman, Keith A Betts, et al.
Dermatology and Therapy
|
May 10, 2024
Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study
Andreas Pinter, Ahmed M Soliman, Irina Pivneva, et al.
Page
of 13